Yeast proteins, compositions thereof, and methods for their preparation and use
Yeast proteins with a zymosan coating and specific amino acid content are produced to address the lack of slowly digested proteins, offering improved gastric digestibility and sustained satiety, suitable for regulating plasma amino acid levels and supporting metabolic health.
Patent Information
- Application Number
- JP2024531424
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-26
- Filing Date
- 2022-11-21
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2042-11-21
AI Technical Summary
There is a lack of slowly digested yeast proteins in existing technologies, which are essential for maintaining protein balance and regulating postprandial plasma amino acid levels, particularly for populations with different needs and conditions.
The production of yeast proteins with a spherical or ellipsoidal shape, wrapped by zymosan, containing 70% protein and 5-30% zymosan, achieved through enzymatic decomposition and thermal extraction, which slows down gastric digestibility.
The yeast proteins exhibit lower gastric digestibility compared to soy and whey proteins, providing sustained satiety and a complete amino acid profile, effectively regulating postprandial plasma amino acid levels and supporting metabolic health.
Smart Images

Figure 2024541534000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to the medical technical field, in particular to yeast proteins, compositions thereof and methods for their production and use. [Background technology]
[0002] Protein is a kind of substance essential for life activities and is a basic organic matter that constitutes cells. The human body needs to keep the body's protein renewed by continuing to ingest protein. After ingested protein is hydrolyzed into amino acids and absorbed by the body through digestion, proteins necessary for the human body are synthesized, and at the same time, new proteins continue to be metabolized and broken down, so that a dynamic balance is always maintained. With the development of modern society, the needs of human life are becoming more and more diverse. In order to meet a healthier lifestyle and to meet the needs of groups of different occupations, different ages, and different needs, foods that maintain the balance of the body's protein for a long time are becoming the focus of attention. Slowly digestible proteins, as such proteins, have the effects of increasing postprandial protein acquisition, reducing the overload of certain organs or certain enzyme metabolism, limiting daily food intake, improving tissue regeneration, filling certain functional disorders in amino acid metabolism, etc. It is urgent to find proteins with slow digestive function.
[0003] Patent Document 1 provides a method for producing protein peptide-slowly digestible starch granules, in which rice-derived starch, protein peptide and water are mixed and then homogenized to obtain a protein peptide-slowly digestible starch complex, which is then spray-dried to obtain the protein peptide-slowly digestible starch granules.
[0004] Patent Document 2 discloses an infant food composition that contains slowly digestible proteins, including casein, which is naturally slowly digested, and which has been pre-denatured to slow down the rate of digestion.
[0005] Yeast protein is a high-quality complete protein found in natural yeast. Yeast protein contains a complete set of amino acids, including the eight types of amino acids essential to the human body. In particular, yeast contains a high amount of lysine, which is found in low amounts in grain-derived proteins. Yeast also has high nutritional value, as the amino acid ratio is close to the ideal amino acid composition recommended by the Food and Agriculture Organization of the United Nations (FAO). Currently, yeast protein is mainly used in the food and feed industries. [Prior art documents] [Patent documents]
[0006] [Patent Document 1] China Patent Application Publication No. 107802001 [Patent Document 2] International Publication No. 1997005785 Summary of the Invention [Problem to be solved by the invention]
[0007] The technical problem that the present invention seeks to solve is the lack of slowly digestible yeast proteins in the prior art.
[0008] In response to the shortcomings of the prior art, a first object of the present invention is to provide a yeast protein which is enveloped on the outside by zymosan, has a spherical or ellipsoidal shape, has a protein content of 70% or more and a zymosan content of 5-30% when the dry weight is taken as 100%, and has a gastric digestibility that is clearly lower than that of soy protein isolate and whey protein. A second object of the present invention is to provide a method for producing the above yeast. A third object of the present invention is to provide a composition of the above yeast. A fourth object of the present invention is to provide use of the above yeast protein and its composition as a slowly digestible protein which can be used for producing a composition for enterally administering to a mammal to adjust postprandial plasma amino acid levels. [Means for solving the problem]
[0009] The technical solutions of the present invention are as follows: The present invention provides a yeast protein, the outside of which is enveloped by zymosan, which is spherical or ellipsoidal, and when the dry weight is taken as 100%, the protein content is 70% or more and the zymosan content is 5 to 30%.
[0010] Preferably, the protein contains isoleucine, leucine, lysine, methionine, phenylalanine, tyrosine, threonine, cysteine, tryptophan, valine, aspartic acid, arginine, glutamic acid, glycine, histidine, alanine, serine and proline.
[0011] Preferably, based on the weight of yeast protein, the isoleucine content is 60 mg / g or more, the leucine content is 90 mg / g or more, the lysine content is 96 mg / g or more, the methionine content is 25 mg / g or more, the phenylalanine content is 49 mg / g or more, the tyrosine content is 49 mg / g or more, the threonine content is 50 mg / g or more, the cysteine content is 14 mg / g or more, and the tryptophan content is 10 mg / g or more. the amount of valine is 13 mg / g or more, the amount of aspartic acid is 55 mg / g or more, the amount of arginine is 53 mg / g or more, the amount of glutamic acid is 109 mg / g or more, the amount of glycine is 47 mg / g or more, the amount of histidine is 30 mg / g or more, the amount of alanine is 59 mg / g or more, the amount of serine is 52 mg / g or more, and the amount of proline is 27 mg / g or more.
[0012] The present invention also provides a method for producing a method for manufacturing a semiconductor device comprising the steps of: (1) adding an enzyme to yeast to perform enzymatic hydrolysis; (2) providing a method for producing the above yeast protein, the method comprising the steps of: subjecting the enzymatic hydrolysis solution obtained in step (1) to thermal extraction, centrifuging the solution, and removing the heavy phase to obtain the yeast protein.
[0013] Preferably, in the above production method, the enzyme described in step (1) is selected from α-mannanase and / or β-glucanase, preferably the amount of the enzyme added is 0.05 to 0.5 wt% of the yeast content, and preferably 0.1 to 0.3 wt%, more preferably the temperature of the enzymatic hydrolysis is 40 to 70°C, and preferably 50 to 60°C, and even more preferably the time of the enzymatic hydrolysis is 8 to 24 hours, and preferably 14 to 18 hours.
[0014] Preferably, in the above production method, in step (1), the yeast is prepared as a solution having a mass concentration of 5 to 15%, preferably 8 to 12%, and preferably the yeast is brewer's yeast or Saccharomyces cerevisiae.
[0015] Preferably, in the above-mentioned production method, the pH of the hot extraction described in step (2) is 7.0 to 8.0, preferably 7.5 to 7.7; the temperature of the hot extraction is preferably 70 to 90°C, preferably 75 to 80°C; and more preferably, the time of the hot extraction is 1 to 2 hours.
[0016] Preferably, the above-mentioned production method further includes a step of drying the yeast protein, in which the yeast protein is prepared as a dispersion having a mass concentration of 5 to 20% and then dried to obtain the yeast protein, and preferably the mass concentration of the dispersion is 10 to 15%.
[0017] The present invention also provides a yeast protein produced by the above-mentioned production method.
[0018] The present invention also provides a yeast protein composition comprising at least the above-mentioned yeast protein.
[0019] Preferably, the yeast protein composition further comprises one or more selected from carbohydrates, lipids, and free amino acids. Preferably, the carbohydrates are one or more of corn syrup, maltodextrin, sucrose, oat flour, corn flour, date powder, adzuki bean powder, kudzu starch, pumpkin powder, chia seeds, and lactose. More preferably, the lipids are one or more of coconut oil, rapeseed oil, corn oil, and soybean lecithin. Even more preferably, the free amino acids are one or more of arginine, L-cystine, L-glutamine, L-glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-proline, L-tryptophan, L-tyrosine, and L-valine.
[0020] The present invention also provides the use of the above yeast protein or the above yeast protein composition in the manufacture of a composition for enteral administration to a mammal to regulate postprandial plasma amino acid levels.
[0021] Preferably, said yeast protein or yeast protein composition is used to prepare a composition that increases post-prandial protein intake.
[0022] Preferably, said yeast proteins or yeast protein compositions are used to prepare compositions which reduce the metabolic overload of specific organs and / or specific enzymes.
[0023] Preferably, said yeast protein or yeast protein composition is used to prepare a composition for restricting daily food intake.
[0024] Preferably, said yeast protein or yeast protein composition is used to prepare a composition which fills a specific functional defect in the metabolism of amino acids.
[0025] Preferably, said yeast protein or yeast protein composition is used to prepare a composition for enhancing tissue regeneration.
[0026] The present invention also provides a food for patients with renal dysfunction, which contains as ingredients, expressed by weight percentage, 1-10% of the above yeast protein, 20-30% carbohydrates, 5-15% lipid compounds, and the remainder water.
[0027] The present invention also provides a meal replacement powder comprising as ingredients, expressed in parts by weight, 5 to 20 parts of the yeast protein, 5 to 20 parts of oat flour, 5 to 25 parts of corn flour, 5 to 20 parts of date powder, 5 to 10 parts of adzuki bean powder, 5 to 10 parts of kudzu starch, 5 to 10 parts of pumpkin powder, and 10 to 30 parts of chia seeds.
[0028] The present invention also provides a food for patients with phenylketonuria, which contains as ingredients, expressed as weight percentages, 1-5% of the above-mentioned yeast protein, 1-5% of free amino acids, 10-20% of carbohydrates, 1-5% of lipid compounds, and the remainder being water. Effect of the Invention
[0029] The beneficial effects of the present invention are as follows: The present invention adopts the process of enzymatic hydrolysis followed by thermal extraction, so that yeast protein still has the structure of yeast cells, and the outside of the protein is enveloped by a layer of zymosan. The presence of zymosan blocks the attack site of digestive enzymes in the body, slowing down the digestion of the protein. In addition, thermal extraction can remove nucleic acids in yeast, reducing the nucleic acid content in yeast protein.
[0030] The yeast protein of the present invention is enveloped on the outside by zymosan, has a spherical or elliptical shape, has a protein content of 70% or more in the yeast protein, has a zymosan content of 5-30%, and has a gastric digestibility that is obviously lower than that of soy protein isolate and whey protein, gives a feeling of fullness after a meal that exceeds that of whey protein, and has the characteristic of being slowly digested, so it is a slowly digestible protein. In addition, the yeast protein of the present invention contains 18 kinds of amino acids, including 8 kinds of amino acids essential to the human body and 2 kinds of semi-essential amino acids, and has a complete variety of amino acids, so it belongs to a complete protein. As a slowly digestible protein, it can be used in the manufacture of a composition for adjusting postprandial plasma amino acid levels by enteral administration to mammals. [Brief description of the drawings]
[0031] [Figure 1] 1 shows the percentage of digestion or absorption of yeast protein produced in Example 1, yeast protein produced in Comparative Example 1, soy protein isolate, and whey protein at different test time points. [Diagram 2] 1 shows the hunger curve of the satiety test in Test Example 2. [Diagram 3] 1 shows the hunger curve of the satiety test in Test Example 2. [Figure 4] 1 is a satiety curve from the satiety test of Test Example 2. [Diagram 5] 1 is a scanning electron microscope image of the yeast protein produced in Example 1 at 1000x magnification. [Figure 6] 1 is a scanning electron microscope image of the yeast protein produced in Example 1 at a magnification of 2000x. [Figure 7] 1 is a scanning electron microscope image of the yeast protein produced in Example 1 at a magnification of 10,000x. [Figure 8] 1 is a scanning electron microscope image of the yeast protein produced in Comparative Example 1 at a magnification of 3000x. [Figure 9] 1 is a scanning electron microscope image of soy protein isolate at 300x magnification. [Figure 10]FIG. 2 is a scanning electron microscope image of the raw material Saccharomyces cerevisiae powder in Example 1 at a magnification of 2000x. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0032] In order to make the objectives, technical solutions and advantages of the present invention more clear, the technical solutions of the present invention are described in detail below. Needless to say, the described embodiments are only some of the embodiments of the present invention, but not all of them. All other embodiments that a person skilled in the art obtains based on the embodiments of the present invention without making any novel work, belong to the protection scope of the present invention.
[0033] The present invention provides a yeast protein, the outside of which is wrapped with zymosan, has a spherical or elliptical shape, and when the dry weight is taken as 100%, the protein content is 70% or more and the zymosan content is 5-30%. The yeast protein of the present invention still has the structure of yeast cells, and the outside of the protein is wrapped with one layer of zymosan, and the presence of the zymosan blocks the attack site of digestive enzymes in the body, slowing down the digestion of the protein. The gastric digestibility of the yeast protein is obviously lower than that of soy protein isolate and whey protein, and the feeling of fullness after eating is higher than that of whey protein, and it has the characteristic of being slowly digested, so it is a slowly digestible protein.
[0034] However, the protein contains isoleucine (IIe), leucine (Leu), lysine (Lys), methionine (Met), phenylalanine (Phe), tyrosine (Tyr), threonine (Thr), cysteine (Cys), tryptophan (Trp), valine (Val), aspartic acid (Asp), arginine (Arg), glutamic acid (Glu), glycine (Gly), histidine (His), alanine (Ala), serine (Ser) and proline (Pro), and preferably, based on the weight of yeast protein, the isoleucine content is 60 mg / g or more, the leucine content is 90 mg / g or more, the lysine content is 96 mg / g or more, the methionine content is 25 mg / g or more, and the furan content is 10 mg / g or more. the phenylalanine content is 49 mg / g or more, the tyrosine content is 49 mg / g or more, the threonine content is 50 mg / g or more, the cysteine content is 14 mg / g or more, the tryptophan content is 13 mg / g or more, the valine content is 55 mg / g or more, the aspartic acid content is 111 mg / g or more, the arginine content is 53 mg / g or more, the glutamic acid content is 109 mg / g or more, the glycine content is 47 mg / g or more, the histidine content is 30 mg / g or more, the alanine content is 59 mg / g or more, the serine content is 52 mg / g or more, and the proline content is 27 mg / g or more.
[0035] The present invention also provides a method for producing a method for manufacturing a semiconductor device comprising the steps of: (1) adding an enzyme to yeast to perform enzymatic hydrolysis; (2) providing a method for producing the above yeast protein, the method comprising the steps of: subjecting the enzymatic hydrolysis solution obtained in step (1) to thermal extraction, centrifuging the solution, and removing the heavy phase to obtain the yeast protein.
[0036] However, the enzyme described in step (1) is selected from α-mannanase and / or β-glucanase, the amount of the enzyme added is 0.05 to 0.5 wt% of the yeast content, and preferably 0.1 to 0.3 wt%, the temperature of the enzymatic hydrolysis is 40 to 70°C, and preferably 50 to 60°C, and the time of the enzymatic hydrolysis is 8 to 24 hours, and preferably 14 to 18 hours.
[0037] The method further includes preparing the yeast as a solution having a mass concentration of 5 to 15%, preferably 8 to 12%, prior to the enzymatic hydrolysis of the yeast in step (1), wherein the yeast is brewer's yeast or Saccharomyces cerevisiae.
[0038] The pH of the hot extraction described in step (2) is 7.0-8.0, preferably 7.5-7.7, the temperature of the hot extraction is preferably 70-90°C, preferably 75-80°C, and more preferably the time of the hot extraction is 1-2 hours.
[0039] The method for producing the yeast protein described above further includes a step of drying the yeast protein, in which the yeast protein is prepared as a dispersion having a mass concentration of 5 to 20% and then dried to obtain the yeast protein. Preferably, the mass concentration of the dispersion is 10 to 15%.
[0040] The present invention also provides a yeast protein produced by the above-mentioned production method.
[0041] The present invention also provides a yeast protein composition comprising at least the above-mentioned yeast protein.
[0042] However, the yeast protein composition further contains one or more selected from carbohydrates, lipids, and free amino acids, the carbohydrates being one or more of corn syrup, maltodextrin, sucrose, oat flour, corn flour, date powder, adzuki bean powder, kudzu starch, pumpkin powder, chia seeds, and lactose, the lipids being one or more of coconut oil, rapeseed oil, corn oil, and soybean lecithin, and the free amino acids being one or more of arginine, L-cystine, L-glutamine, L-glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-proline, L-tryptophan, L-tyrosine, and L-valine.
[0043] The present invention also provides the use of the yeast protein or yeast protein composition described above in the manufacture of a composition for enteral administration to a mammal to regulate postprandial plasma amino acid levels, thereby 1) Increase postprandial protein intake; and / or 2) avoiding metabolic overload of certain organs and / or certain enzymes, and / or 3) The satiating effect of these proteins limits daily food intake, and / or 4) correcting a specific dysfunction in the metabolism of amino acids, more specifically, correcting an enzymatic deficiency, and / or 5) Improve tissue regeneration.
[0044] As a slowly digestible protein, the yeast protein of the present invention can avoid metabolic overload of certain organs and / or certain enzymes. After eating a meal containing various nitrogenous compounds (proteins, peptides, amino acids), the liver tries to maintain the concentration of amino acids at physiological limits by decomposing some of the amino acids from the meal. The adequate amount of amino acids from the meal can reduce the excessive movement of the diseased organ and thus avoid its overworking. Renal impairment patients need to severely limit their protein intake, generally by eating a low-protein diet to reduce the production of nitrogen metabolites, and the intake of slowly digestible proteins has the effect of reducing the production of nitrogen that is later excreted by the kidney and distributing this production over a long period of time, improving the satiety effect of such proteins and thus obtaining a better tolerance to such meals.
[0045] For populations with a deficiency in certain digestive enzymes, for example trypsin, the ingestion of the yeast protein of the invention helps to improve the digestive process. Such an advantage is ensured by reducing the amount of substrate that the pancreatic proteolytic enzyme in question hydrolyzes, resulting in a better enzyme / substrate ratio.
[0046] Among diseases in which there is a dysfunction in the metabolism of amino acids and, more specifically, in which there is a deficiency of enzymes in the degradation pathways of these amino acids (e.g. phenylalaninemia and phenylketonuria, hypertyrosinemia, histidinemia, homocystinuria, branched-chain amino acid metabolism disorders), the accumulation of these amino acids or one of their degradation products leads to neurological and clinical syndromes. To avoid such accumulation, dietary therapy is used, which consists of a diet that does not contain or contains very small amounts of the amino acids related to the occurrence of the disease. Certain products developed for this population contain free amino acids or highly hydrolyzed proteins. However, these mixtures do not have a pleasant taste. Also, to avoid diarrhea due to the high permeability of the products, the consumer must consume these products with small meals. The yeast protein of the present invention has a slow digestion rate and provides a small amount of the proteins of the related amino acids, improving the taste of the meal and improving its tolerability, thereby limiting the risk of diarrhea, avoiding amino acid fluctuations in the plasma, and increasing the postprandial protein intake.
[0047] The yeast protein of the present invention can be used as a slowly digestible protein for the elderly, and compared with young people, the amount of protein in the body of the elderly is reduced, which will reduce the impact on autonomy, resistance to attacks (diseases, various adversities) and recovery ability after attacks, but the slowly digestible protein can continue to supply protein to the body by being slowly digested. In addition, renal function decreases with age. Therefore, the slowly digestible protein can better maintain the amount of protein and avoid overloading the kidney.
[0048] The present invention also provides a food for patients with renal dysfunction, which contains, by weight percentage, 1-10% of the above yeast protein, 20-30% carbohydrates, 5-15% lipid compounds, and the remainder water.
[0049] The present invention also provides a meal replacement powder comprising as ingredients, expressed in parts by weight, 5 to 20 parts of the yeast protein, 5 to 20 parts of oat flour, 5 to 25 parts of corn flour, 5 to 20 parts of date powder, 5 to 10 parts of adzuki bean powder, 5 to 10 parts of kudzu starch, 5 to 10 parts of pumpkin powder, and 10 to 30 parts of chia seeds.
[0050] The present invention also provides a food for patients with phenylketonuria which contains, expressed by weight percentage, 1 to 5% of the above-mentioned yeast protein, 1 to 5% of free amino acids, 10 to 20% of carbohydrates, 1 to 5% of lipid compounds, and the remainder being water.
[0051] The beneficial effects of the present invention will be further illustrated below using specific examples and test examples.
[0052] The information on the reagents and equipment used in the examples of the present invention is shown in Tables 1-1 and 1-2. [Table 1-1] [Table 1-2]
[0053] Example 1 Add 10 kg of Saccharomyces cerevisiae powder to purified water to prepare 200 kg of solution, add dilute hydrochloric acid to adjust the pH to 5.0, adjust the temperature to 40°C, add 5 g of α-mannanase to enzymatically decompose for 24 hours, adjust the pH to 7.0 with sodium hydroxide, raise the temperature to 70°C and keep warm for 1 hour, lower the temperature to 50°C, centrifuge at 5000 rpm for 20 minutes, remove the upper liquid, and then prepare the lower solid as a dispersion with a mass concentration of 5%, and spray-dry to obtain the yeast protein product.
[0054] The protein content in the yeast protein produced in the examples was measured using the Kjeldahl method, and the measurement results are shown in Table 2.
[0055] Next, the moisture, zymosan and nucleic acid contents of the produced yeast protein were measured by the following methods. The measurement results are shown in Table 2.
[0056] 1. Zymosan Measurement Method Determination of Zymosan Content Using Liquid Chromatography: (1) Sample treatment: 400 mg (precision 0.1 mg) of sample is accurately weighed and placed in a 20 mL screw-top heat-resistant glass small test tube, 6.0 mL of hydrochloric acid (37%) is added, and the vial is carefully capped and mixed with a vortex mixer to obtain a uniform suspension. The vial is placed in a 30°C water bath for 45 minutes, and mixed once every 15 minutes by shaking with a vortex mixer. The suspension is then quantitatively transferred to a 200 mL Dewar flask, and the small test tube is washed multiple times with about 100-120 mL of water, and the washings are placed in the Dewar flask. The Dewar flask is placed in an autoclave and treated at 121°C for 60 minutes. The solution is removed and cooled, and the pH of the solution is adjusted to 6-7 with sodium hydroxide solution, and then the volume is adjusted to 200 mL. The solution is filtered using a cellulose acetate membrane with a pore size of 0.45 μm. At the same time, 200 mg of dextran standard is accurately weighed and treated in the same manner as the sample.
[0057] (2) Chromatography conditions: pure water is used as the mobile phase, the flow rate is 0.5 mL / min, the column temperature is 80° C., and loading is started after the baseline of the instrument has stabilized.
[0058] (3) Preparation of the calibration curve: 1 mL, 2 mL, 3 mL, 4 mL, and 5 mL of the mannose and glucose standard solutions are drawn up into 10 mL measuring flasks, and the volume is adjusted to the mark with high-purity water to obtain mixed standards with mannose and glucose concentrations of 200 mg / L, 400 mg / L, 600 mg / L, 800 mg / L, and 1000 mg / L, respectively. Accurately load 20 μL under the above chromatography conditions, obtain the regression equation between the peak area and the mass concentration of the standard, and prepare the calibration curve.
[0059] (4) Measurement of the sample and standard substance: Inject the treated sample, mannose and dextran standard substances into the chromatograph under the same chromatographic conditions, and record the retention time and peak area of each peak. Qualitative determination is based on the retention time of the sugar standard substance peak, and quantitative determination is based on the peak area of the sugar standard substance peak.
[0060] (5) Calculate the content of dextran or mannan oligosaccharides using the formula below.
number
number
[0061] 2. Measurement method of nucleic acid content Total phosphorus is measured according to GB / T 6437 "Spectrophotometric method for the determination of total phosphorus in feed" and calculated by the formula: nucleic acid content = total phosphorus × 340 / 32. The specific steps are as follows: after digesting the phosphorus in the nucleic acid of yeast hydrolysate, water-soluble inorganic phosphorus is produced, which is reacted with ammonium molybdate to produce ammonium phosphomolybdate. Under acidic conditions, molybdenum blue is produced using a reducing agent, the color intensity of which is directly proportional to the content of P2O5 and follows the Beer-Lambert law, and the absorbance at 700nm is measured by a spectrophotometer.
[0062] 3. Moisture measurement method Using the method of 6.2 of the Chinese national standard GB / T 23530-2009, a given mass of sample is dried at 103°C for 4 hours until it reaches a constant weight, and then weighed to calculate the moisture content.
[0063] Example 2 30 kg of Saccharomyces cerevisiae powder is added to purified water to prepare 200 kg of solution, and dilute hydrochloric acid is added to adjust the pH to 5.0, the temperature is adjusted to 50°C, and 30 g of β-glucanase is added for enzymatic degradation for 18 hours. The pH is adjusted to 7.5 using sodium hydroxide, the temperature is raised to 80°C, and the mixture is kept warm for 2 hours. The temperature is lowered to 50°C, and the mixture is centrifuged at 5000 rpm for 20 minutes to remove the upper liquid layer. The lower solid layer is then prepared as a dispersion with a mass concentration of 10%, and spray-dried to obtain the yeast protein product.
[0064] According to the same method as in Example 1, the protein content, zymosan content, moisture content and nucleic acid content of the prepared yeast protein were measured, and the results are shown in Table 2.
[0065] Example 3 16 kg of Saccharomyces cerevisiae powder is added to purified water to prepare 200 kg of solution, and diluted hydrochloric acid is added to adjust the pH to 5.0, the temperature is adjusted to 60°C, 24 g of α-mannanase and 24 g of β-glucanase are added to perform enzymatic hydrolysis for 14 hours. The pH is adjusted to 7.7 using sodium hydroxide, the temperature is raised to 75°C, and the mixture is kept warm for 2 hours. The temperature is lowered to 50°C, and the mixture is centrifuged at 5000 rpm for 20 minutes to remove the upper liquid layer. The lower solid layer is then prepared as a dispersion with a mass concentration of 15%, and spray-dried to obtain the yeast protein product.
[0066] According to the same method as in Example 1, the protein content, zymosan content, moisture content and nucleic acid content of the prepared yeast protein were measured, and the results are shown in Table 2.
[0067] Example 4 24 kg of Saccharomyces cerevisiae powder is added to purified water to prepare 200 kg of solution, and dilute hydrochloric acid is added to adjust the pH to 5.0, the temperature is adjusted to 70°C, and 120 g of α-mannanase is added for enzymatic degradation for 8 hours. The pH is adjusted to 7.7 using sodium hydroxide, the temperature is raised to 90°C, and the mixture is kept warm for 1.5 hours. The temperature is lowered to 50°C, and the mixture is centrifuged at 5000 rpm for 20 minutes to remove the upper liquid layer. The lower solid layer is then prepared as a dispersion with a mass concentration of 20%, and spray-dried to obtain the yeast protein product.
[0068] According to the same method as in Example 1, the protein content, zymosan content, moisture content and nucleic acid content of the prepared yeast protein were measured, and the results are shown in Table 2.
[0069] Example 5 Purify water by reverse osmosis membrane, take 1L water and heat it to 70℃, add 50g yeast protein prepared in Example 1, 151g corn syrup solids, 93g maltodextrin and 26g sucrose, then add 40g coconut oil, 24g rapeseed oil, 11g corn oil and 4.8g soy lecithin, inject steam to homogenize the mixture at 150℃, cool it to 75℃, add 0.8g minerals and 1.5g water-soluble vitamins, and later aseptically package in a container to obtain a drink for patients with renal dysfunction, the energy density of which is 200kcal / 100mL.
[0070] Example 6 The composition was 20 g of the yeast protein produced in Example 1, 5 g of oat flour, 10 g of corn flour, 15 g of date powder, 5 g of adzuki bean powder, 5 g of kudzu starch, 10 g of pumpkin powder, and 15 g of chia seeds. The above ingredients are sieved and then directly packaged to obtain the meal replacement powder.
[0071] Example 7 Water was purified using a reverse osmosis membrane, 1 L of water was taken and heated to 70°C, and 17 g of the yeast protein produced in Example 1, 1 g of arginine, 1 g of L-cystine, 1 g of L-glutamine, 1 g of L-glycine, 1 g of L-histidine, 1.5 g of L-isoleucine, 2 g of L-leucine, 2 g of L-lysine, 1 g of L-methionine, 1 g of L-proline, 1 g of L-tryptophan, 2 g of L-tyrosine, and 0.5 g of L-valine were added. Add 130g of lactose, then add 24g of rapeseed oil, 16g of corn oil, 0.5g of soybean lecithin and 0.5g of fat-soluble vitamins, inject steam to heat the mixture at 80°C for 5 minutes, cool it to 60°C, add 0.8g of minerals and 1.5g of water-soluble vitamins, homogenize in two stages, first at 10 MPa and then at 7 MPa, and finally spray dry to obtain a food for phenylketonuria patients with a moisture content of 4%.
[0072] Comparative Example 1 Yeast protein is prepared according to the method of CN109198156.
[0073] 10 kg of Saccharomyces cerevisiae powder was added to purified water to prepare 200 kg of solution, and the pH was adjusted to 5.0 by adding dilute hydrochloric acid, the temperature was adjusted to 40°C, and 5 g of α-mannanase was added for enzymatic decomposition for 24 hours. The mixture was centrifuged at 5000 rpm for 20 minutes, and the upper layer liquid was removed. Then, the precipitate was dispersed in 60 kg of water, and the pH was adjusted to 7.0 by using sodium hydroxide. The above liquid was homogenized six times at a pressure of 800 bar, and the homogenization flow rate was 1 m. 3 / hour and the crude protein is lyophilized to obtain the yeast protein product. [Table 2]
[0074] Characterization of the yeast proteins produced in Example 1 and Comparative Example 1 above: 1. Scanning Electron Microscope (SEM) Images Scanning electron microscope (SEM) tests were performed on the raw materials Saccharomyces cerevisiae powder of Example 1, the soy protein isolate, the yeast protein produced in Example 1, and the yeast protein produced in Comparative Example 1. Scanning electron microscope images of the raw materials Saccharomyces cerevisiae powder of Example 1, the soy protein isolate, and the yeast protein produced in Example 1 are shown in Figures 5 to 7, the scanning electron microscope image of the yeast protein produced in Comparative Example 1 is shown in Figure 8, the scanning electron microscope image of the soy protein isolate is shown in Figure 9, and the scanning electron microscope image of the raw material yeast powder of Example 1 is shown in Figure 10.
[0075] As can be seen from Figures 5 to 10, the yeast protein produced in Example 1 is spherical or elliptical, similar to the structure of yeast cell wall powder, with the protein being enveloped by the cell wall. The soy protein isolate has an irregular spherical shape due to the exposed protein (soy protein is mainly composed of globulin). The yeast protein in Comparative Example 1 has undergone homogenization and is partially elliptical, similar to a complete yeast cell, but the wall-destroying action of homogenization releases some of the protein by wall destruction.
[0076] (Test Example 1) Using an in vitro simulated digestion method, the digestion and absorption of yeast protein (YPC) prepared in Example 1, yeast protein (YPT) prepared in Comparative Example 1, soy protein isolate (SPI) and whey protein (WPC) were compared, and the method was as follows. 1) Gastric phase (fed state): Digest for 2 hours at 37°C, simultaneously stirring and mixing to reduce the pH according to a sigmoidal curve. Normalized pepsin activity is provided by measuring the absorbance at 280 nm of the soluble product after hemoglobin (reference protein) is digested by trichloroacetic acid (TCA). Add phosphatidylcholine, SHIME nutrient medium, sodium chloride and potassium chloride.
[0077] 2) Small intestine stage (fed state): digestion for 3 hours at 37°C, stirring and mixing at the same time to raise the pH to 7.4. The added pancreatin is an animal pancreas extract, and the added bile salts are 0.01 mol / L bovine bile extract (for taurine and glycocholate, bovine bile is closer to human bile than porcine bile). Also, during the process of digestion, the bile salts are diluted to simulate the occurrence in the duodenum, jejunum and ileum. At the end of digestion, static dialysis (cutoff=14 kDa) using cellulose membrane is used to simulate the absorption process at the small intestine level. The small intestine suspension is introduced into the dialysis tube to gradually remove small molecules such as digested amino acids from the upper digestive tract matrix, simulating different regions of the digestive tract in the body by optimizing the digestive conditions (pH curve, digestion time), and all tests are performed in triplicate.
[0078] 3) Determine the degree of protein hydrolysis by quantitative non-protein nitrogen (NPN) measurement. NPN may be determined by treating the sample with TCA (trichloroacetic acid), which precipitates the proteins, followed by filtration. The proteins in the filtrate are derived from free amino acids and small peptides formed during protein digestion (and can be selectively detected by spectrophotometry). The protein content is determined by total Kjeldahl analysis on the initial and TCA-precipitated samples, which distinguishes between digested and undigested protein fractions. The protein digestibility or absorption rate is tabulated for the following different time points of sample analysis: (1) initial product (ST 0), (2) end of digestion in the stomach (ST end), (3) after 30 minutes of digestion in the small intestine (SI 30), (4) end of digestion in the small intestine (SI end), (5) dialysis of the mixed suspension at 1, 2 and 3 hours (absorbed protein components). The results are shown in Figure 1. Digestion rate=(X-X1) / X Absorption rate = X2 / X where X1 is the nitrogen content of the TCA-precipitated protein in %. X2 is the total nitrogen content in the dialysate in %. X is the total nitrogen content of the particular sample tabulated, in %.
[0079] 4) Measurement of background protein content A control group will be added to the study and the background protein content will be measured and corrected by the Kjeldahl method to simulate different components of the upper gastrointestinal tract.
[0080] The test results are shown in Figure 1. As can be seen from Figure 1, the digestion and absorption level of WPC in the distal small intestine is significantly higher than that of YPC, YPT and SPI (P<0.01), but there is no significant difference in the overall digestibility of YPC, YPT and SPI (P>0.05), and there is no significant difference in the absorption rates of the four protein raw materials when compared pair by pair (P>0.05). However, the digestibility in the stomach varies depending on the protein. Compared with the yeast protein YPC (13.4%) produced in Example 1 and the yeast protein YPT (15.6%) produced in Comparative Example 1, the digestion in the stomach of whey protein WPC (38.2%) and soy protein isolate SPI (25.1%) is more obvious, and the digestion of yeast protein in the digestive tract is obviously slower than that of whey protein and soy protein isolate, and the digestion of yeast protein YPC produced in Example 1 is slower than that of yeast protein YPT produced in Comparative Example 1.
[0081] (Test Example 2) A satiety test was carried out on the yeast protein (YPC) prepared in Example 1 of the present invention, the yeast protein (YPT) prepared in Comparative Example 1, and the whey protein (WPC) according to the following method. The mean age was 29 ± 3 years and the mean body mass index was 22.3 ± 1.7 kg / m 2 The study recruited 15 volunteers to participate in the two-day study, eating one of three different meals each day. These subjects refrained from drinking any alcohol the day before the study, had a small dinner by 8 p.m., and fasted until the study began. Three meals were eaten each day during the study. 1) A small, standard breakfast consisting of a slice of wholemeal bread, 15g of jam, and milk (150 kcal), eaten at 7:45 a.m. and taking 10-15 minutes.
[0082] 2) The test meal (5 trial volunteers will have meal 1, 5 trial volunteers will have meal 2, and 5 trial volunteers will have meal 3 as shown in Table 2) will be eaten at 10:00 a.m. and will take approximately 15 minutes.
[0083] 3) A meal based on pasta with tomato sauce, eaten at 1pm.
[0084] Study volunteers record their gastric hunger, hunger and fullness on a visual analogue scale (10 cm) at 30 minute intervals between 10 am and 1 pm.
[0085] At the 1 pm meal, study volunteers review and weigh the pasta and tomato sauce consumed until full. They record in a notebook the foods eaten for the remainder of the study day. Food composition tables by McCance and Widdowson (1991) can be used to estimate the number of calories consumed from the amounts of various foods eaten at lunch and for the remainder of the day. [Table 3]
[0086] The test results are shown in Figure 2. Figures 2 to 4 show the curves of "hunger", "starvation" and "satiety". The yeast protein (YPC) and whey protein concentrate (WPC) produced in Example 1 and the yeast protein (YPT) produced in Comparative Example 1 behave differently. When eating a meal based on the yeast protein produced in Example 1, hunger and appetite occur late, and the yeast protein produced in Example 1 causes a long-lasting feeling of fullness in the stomach.
[0087] The average calorie delivery during the meal and for the remainder of the day after the first consumption of whey protein, yeast protein produced in Comparative Example 1, and yeast protein produced in Example 1 are compared. As shown in Table 3 and the results in Table 3, such delivery is reduced when the meal is the yeast protein produced in Example 1 (i.e., Meal 2).
[0088] These results show that eating the yeast protein produced in Example 1 gives a greater feeling of satiety than eating whey protein and the yeast protein produced in Comparative Example 1. [Table 4]
[0089] (Test Example 3) The amino acid composition of the yeast protein (YPC) produced in Example 1 and the yeast protein (YPT) produced in Comparative Example 1 is measured according to GB 5009.124-2016 "Determination of Amino Acids in Foods Related to National Standards for Food Safety". The average is taken from two measurements. YPC and YPT are compared according to the amino acid score pattern proposed by FAO / WHO in 1973 and the whole egg protein pattern proposed by the Chinese Institute of Preventive Medical Science, Nutrition and Food Hygiene, and the amino acid score (AAS) and chemical score (CS) are calculated according to formula (1) and formula (2).
number
number
[0090] The test results are shown in Table 4. As can be seen from Table 4, the yeast protein YPC produced in Example 1 and the yeast protein YPT produced in Comparative Example 1 both contain 18 kinds of amino acids, including 8 kinds of amino acids essential for the human body and 2 kinds of semi-essential amino acids, and belong to complete proteins because of the complete amino acid variety. According to the amino acid pattern proposed by FAO / WHO, the total amount of essential amino acids should reach 40% or more of the total amount of amino acids, and the ratio of the total amount of essential amino acids to the total amount of non-essential amino acids should be 0.6 or more. When the amino acid composition of a particular protein is close to the ideal pattern of FAO / WHO, the higher this ratio, the higher the nutritional value of the protein. The amino acid composition of YPC and YPT is close to the ideal pattern, and the ratio of essential amino acids to non-essential amino acids reaches 1.03, which indicates that the yeast protein produced in Example 1 and the yeast protein produced in Comparative Example 1 have the same nutritional value.
[0091] As can be seen from the above, the yeast protein of the present invention is enveloped by zymosan on the outside, has a spherical or elliptical shape, has a protein content of 70% or more in the yeast protein, has a zymosan content of 5-30%, and has a gastric digestibility that is obviously lower than that of soy protein isolate and whey protein, and has a feeling of fullness after a meal that exceeds that of whey protein. Since the yeast protein of the present invention has the characteristics of being slowly digested, it is a slowly digestible protein. In addition, the yeast protein of the present invention contains 18 kinds of amino acids, including 8 kinds of amino acids essential for the human body and 2 kinds of semi-essential amino acids, and has a complete variety of amino acids, it belongs to a complete protein. As a slowly digestible protein, it can be used in the manufacture of a composition for adjusting postprandial plasma amino acid levels by enteral administration to mammals.
[0092] The above is merely a preferred embodiment of the present invention, and does not impose any formal limitations on the present invention. If any changes, equivalent replacements, improvements, etc. are made within the scope and spirit of the present invention, they shall all be included in the protection scope of the present invention.
[0093] (Additional Note) (Appendix 1) A yeast protein characterized in that the outside is enveloped by zymosan, is spherical or ellipsoidal, and when the dry weight of zymosan is taken as 100%, the protein content is 70% or more and the zymosan content is 5 to 30%.
[0094] (Appendix 2) 2. The yeast protein according to claim 1, characterized in that the protein contains isoleucine, leucine, lysine, methionine, phenylalanine, tyrosine, threonine, cysteine, tryptophan, valine, aspartic acid, arginine, glutamic acid, glycine, histidine, alanine, serine and proline.
[0095] (Appendix 3) Based on the weight of yeast protein, the isoleucine content is 60 mg / g or more, the leucine content is 90 mg / g or more, the lysine content is 96 mg / g or more, the methionine content is 25 mg / g or more, the phenylalanine content is 49 mg / g or more, the tyrosine content is 49 mg / g or more, the threonine content is 50 mg / g or more, the cysteine content is 14 mg / g or more, the tryptophan content is 13 mg / g or more, and the varietal The yeast protein according to claim 1 or 2, characterized in that the yeast protein has a guanine content of 55 mg / g or more, an aspartic acid content of 111 mg / g or more, an arginine content of 53 mg / g or more, a glutamic acid content of 109 mg / g or more, a glycine content of 47 mg / g or more, a histidine content of 30 mg / g or more, an alanine content of 59 mg / g or more, a serine content of 52 mg / g or more, and a proline content of 27 mg / g or more.
[0096] (Appendix 4) (1) adding an enzyme to yeast to perform enzymatic hydrolysis; (2) A method for producing a yeast protein according to any one of Appendices 1 to 3, comprising the steps of: (i) subjecting the enzymatic hydrolysis liquid obtained in step (1) to thermal extraction, centrifuging the liquid to remove the heavy phase, and obtaining the yeast protein.
[0097] (Appendix 5) The production method described in Appendix 4, characterized in that the enzyme described in step (1) is selected from α-mannanase and / or β-glucanase, preferably the amount of the enzyme added is 0.05 to 0.5 wt% and preferably 0.1 to 0.3 wt% of the yeast content, more preferably the temperature of the enzymatic hydrolysis is 40 to 70°C and preferably 50 to 60°C, and even more preferably the time of the enzymatic hydrolysis is 8 to 24 hours and preferably 14 to 18 hours.
[0098] (Appendix 6) The method according to claim 4 or 5, wherein in step (1), yeast is prepared as a solution having a mass concentration of 5 to 15%, preferably 8 to 12%, and preferably the yeast is brewer's yeast or Saccharomyces cerevisiae.
[0099] (Appendix 7) The method for producing the present invention as described in any one of Appendices 4 to 6, characterized in that the pH of the hot extraction described in step (2) is 7.0 to 8.0, preferably 7.5 to 7.7, the temperature of the hot extraction is preferably 70 to 90°C, preferably 75 to 80°C, and more preferably the time of the hot extraction is 1 to 2 hours.
[0100] (Appendix 8) The method for producing the yeast protein according to any one of claims 4 to 7, further comprising a step of drying the yeast protein, the step of preparing the yeast protein as a dispersion having a mass concentration of 5 to 20% and then drying the yeast protein, preferably characterized in that the mass concentration of the dispersion is 10 to 15%.
[0101] (Appendix 9) A yeast protein produced by the production method according to any one of claims 4 to 8.
[0102] (Appendix 10) A yeast protein composition comprising at least a yeast protein according to any one of appendices 1 to 3 or appendix 9.
[0103] (Appendix 11) The yeast protein composition further comprises one or more selected from carbohydrates, lipids and free amino acids, preferably the carbohydrates are one or more of corn syrup, maltodextrin, sucrose, oat flour, corn flour, date powder, adzuki bean powder, kudzu starch, pumpkin powder, chia seeds and lactose, more preferably the lipids are one or more of coconut oil, canola oil, corn oil and soy lecithin, and even more preferably the free amino acids are one or more of arginine, L-cystine, L-glutamine, L-glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-proline, L-tryptophan, L-tyrosine and L-valine.
[0104] (Appendix 12) 2. Use of a yeast protein according to any one of Appendix 1 to 3 or Appendix 9, or a composition according to Appendix 10 or 11, in the manufacture of a composition for enteral administration to a mammal to adjust postprandial plasma amino acid levels.
[0105] (Appendix 13) 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for the manufacture of a composition for increasing postprandial protein intake.
[0106] (Appendix 14) 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for producing a composition which reduces the metabolic overload of specific organs and / or specific enzymes.
[0107] (Appendix 15) 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for the manufacture of a composition for limiting daily food intake.
[0108] (Appendix 16) 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for producing a composition for filling a specific dysfunction in the metabolism of amino acids.
[0109] (Appendix 17) 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for the manufacture of a composition that improves tissue regeneration.
[0110] (Appendix 18) A food for patients with renal dysfunction, characterized in that, when expressed as weight percentage, the ingredients are 1 to 10% of a yeast protein described in any one of Appendix 1 to 3 or Appendix 9, 20 to 30% carbohydrates, 5 to 15% lipid compounds, and the remainder is water.
[0111] (Appendix 19) A meal replacement powder comprising as ingredients, expressed in parts by weight, 5 to 20 parts of a yeast protein as described in any one of Appendix 1 to 3 or Appendix 9, 5 to 20 parts of oat flour, 5 to 25 parts of corn flour, 5 to 20 parts of date powder, 5 to 10 parts of adzuki bean powder, 5 to 10 parts of kudzu starch, 5 to 10 parts of pumpkin powder, and 10 to 30 parts of chia seeds.
[0112] (Appendix 20) A food for patients with phenylketonuria, characterized in that, when expressed as weight percentage, the ingredients are 1 to 5% of a yeast protein described in any one of Appendix 1 to 3 or Appendix 9, 1 to 5% of free amino acids, 10 to 20% of carbohydrates, and 1 to 5% of lipid compounds, with the remainder being water. [Explanation of symbols]
[0113] YPC Yeast protein produced in Example 1 YPT Yeast protein produced in Comparative Example 1 WPC Whey Protein SPI Soy Protein Isolate
Claims
1. A yeast protein characterized in that the outside is wrapped in zymosan, is spherical or ellipsoidal, and when the dry weight of zymosan is taken as 100%, the protein content is 70% or more and the zymosan content is 5 to 30%.
2. 2. The yeast protein of claim 1, wherein the protein contains isoleucine, leucine, lysine, methionine, phenylalanine, tyrosine, threonine, cysteine, tryptophan, valine, aspartic acid, arginine, glutamic acid, glycine, histidine, alanine, serine and proline.
3. Based on the weight of yeast protein, the isoleucine content is 60 mg / g or more, the leucine content is 90 mg / g or more, the lysine content is 96 mg / g or more, the methionine content is 25 mg / g or more, the phenylalanine content is 49 mg / g or more, the tyrosine content is 49 mg / g or more, the threonine content is 50 mg / g or more, the cysteine content is 14 mg / g or more, the tryptophan content is 13 mg / g or more, and the varietal protein content is 10 mg / g or more.
3. The yeast protein according to claim 1 or 2, characterized in that the yeast protein has an amino acid content of 55 mg / g or more, an aspartic acid content of 111 mg / g or more, an arginine content of 53 mg / g or more, a glutamic acid content of 109 mg / g or more, a glycine content of 47 mg / g or more, a histidine content of 30 mg / g or more, an alanine content of 59 mg / g or more, a serine content of 52 mg / g or more, and a proline content of 27 mg / g or more.
4. (1) adding an enzyme to yeast to perform enzymatic degradation; (2) a step of subjecting the enzymatic hydrolysis liquid obtained in step (1) to thermal extraction, centrifuging the liquid to remove the heavy phase, and obtaining the yeast protein. The method for producing a yeast protein according to any one of claims 1 to 3, further comprising the steps of:
5. The method according to claim 4, characterized in that the enzyme described in step (1) is selected from α-mannanase and / or β-glucanase, preferably the amount of the enzyme added is 0.05 to 0.5 wt %, and preferably 0.1 to 0.3 wt %, of the yeast content, more preferably the temperature of the enzymatic hydrolysis is 40 to 70°C, and preferably 50 to 60°C, and even more preferably the time of the enzymatic hydrolysis is 8 to 24 hours, and preferably 14 to 18 hours.
6. 6. The method according to claim 4 or 5, characterized in that in step (1) the yeast is prepared as a solution having a mass concentration of 5 to 15%, preferably 8 to 12%, and preferably the yeast is brewer's yeast or Saccharomyces cerevisiae.
7. The method according to any one of claims 4 to 6, characterized in that the pH of the hot extraction described in step (2) is 7.0-8.0, preferably 7.5-7.7, preferably the temperature of said hot extraction is 70-90°C, preferably 75-80°C, more preferably the time of said hot extraction is 1-2 hours.
8. 8. The method according to claim 4, further comprising a step of drying the yeast protein, in which the yeast protein is prepared as a dispersion having a mass concentration of 5 to 20% and then dried, preferably the mass concentration of the dispersion being 10 to 15%.
9. A yeast protein produced by the method according to any one of claims 4 to 8.
10. A yeast protein composition comprising at least the yeast protein according to any one of claims 1 to 3 or claim 9.
11. The yeast protein composition further comprises one or more selected from the group consisting of carbohydrates, lipids, and free amino acids, and preferably the carbohydrates are one or more of corn syrup, maltodextrin, sucrose, oat flour, corn flour, date powder, adzuki bean powder, kudzu starch, pumpkin powder, chia seeds, and lactose, more preferably the lipids are one or more of coconut oil, canola oil, corn oil, and soy lecithin, and even more preferably the free amino acids are one or more of arginine, L-cystine, L-glutamine, L-glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-proline, L-tryptophan, L-tyrosine, and L-valine.
12. Use of a yeast protein according to any one of claims 1 to 3 or claim 9 or a composition according to claim 10 or 11 in the manufacture of a composition for enteral administration to a mammal to regulate postprandial plasma amino acid levels.
13. 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for the manufacture of a composition which increases post-prandial protein intake.
14. 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for producing a composition which relieves the metabolic overload of specific organs and / or specific enzymes.
15. 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for the manufacture of a composition for limiting daily food intake.
16. 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for producing a composition which fills a specific dysfunction in the metabolism of amino acids.
17. 13. The use according to claim 12, characterized in that the yeast protein or yeast protein composition is used for the manufacture of a composition for improving tissue regeneration.
18. A food for patients with renal dysfunction, characterized in that the ingredients, expressed as weight percentages, are 1 to 10% of the yeast protein according to any one of claims 1 to 3 or claim 9, 20 to 30% of carbohydrates, 5 to 15% of lipid compounds, and the remainder being water.
19. A meal replacement powder comprising, as ingredients, expressed in parts by weight, 5 to 20 parts of the yeast protein according to any one of claims 1 to 3 or claim 9, 5 to 20 parts of oat flour, 5 to 25 parts of corn flour, 5 to 20 parts of date powder, 5 to 10 parts of adzuki bean powder, 5 to 10 parts of kudzu starch, 5 to 10 parts of pumpkin powder, and 10 to 30 parts of chia seeds.
20. A food for patients with phenylketonuria, characterized in that, when expressed as weight percentages, the ingredients are 1 to 5% of the yeast protein described in any one of claims 1 to 3 or claim 9, 1 to 5% of free amino acids, 10 to 20% of carbohydrates, 1 to 5% of lipid compounds, and the remainder is water.
Citation Information
Patent Citations
Slow-digesting proteins and their use
JP2002527457A
Method of producing yeast protein
JP2013053083A
Yeast protein-containing composition
JP2020183364A
Protein peptide-slowly digestible starch granules and preparation method thereof
CN107802001A
Protein composition
WO1997005785A1
